Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0001193125-26-033752

Options or other derivatives

  • General Counsel acquired 716,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sermon Charles · General Counsel

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-02-01 Grant or award : show line 1 in the form Share Options (Right to buy) +315,750 315,750 D
2026-02-01 Grant or award : show line 2 in the form Share Options (Right to buy) +105,250 105,250 D
2026-02-01 Grant or award : show line 3 in the form Share Options (Right to buy) +295,000 295,000 D
Loading xslF345X05/ownership.xml…